Report for Gil DW

General

Full name : Gil Daniel W

First name : Daniel W

Mail : Department of Biological Sciences, Allergan, Inc., Irvine CA 92612

Zip Code :

City :

Country : USA

Email :

Phone :

Fax :

Website :

Directory :

References (5)

Title : Exploring the potential for subtype-selective muscarinic agonists in glaucoma - Gil_2001_Life.Sci_68(22-23)_2601
Author(s) : Gil DW , Spalding TA , Kharlamb A , Skjaerbaek N , Uldam A , Trotter C , Li D , WoldeMussie E , Wheeler L , Brann M
Ref : Life Sciences , 68 :2601 , 2001
Abstract : Gil_2001_Life.Sci_68(22-23)_2601
ESTHER : Gil_2001_Life.Sci_68(22-23)_2601
PubMedSearch : Gil_2001_Life.Sci_68(22-23)_2601
PubMedID: 11392632

Title : Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation - Gil_1997_Invest.Ophthalmol.Vis.Sci_38_1434
Author(s) : Gil DW , Krauss HA , Bogardus AM , WoldeMussie E
Ref : Invest Ophthalmol Vis Sci , 38 :1434 , 1997
Abstract : Gil_1997_Invest.Ophthalmol.Vis.Sci_38_1434
ESTHER : Gil_1997_Invest.Ophthalmol.Vis.Sci_38_1434
PubMedSearch : Gil_1997_Invest.Ophthalmol.Vis.Sci_38_1434
PubMedID: 9191607

Title : Poster: Muscarinic receptors in human ciliary muscle identified by polymerase chain reaction (PCR) and immunoprecipitation -
Author(s) : Gil DW , Breen TS , Bogardus AM , WoldeMussie E , Wolfe BB
Ref : Life Sciences , 52(5-6) :573 , 1993
PubMedID:

Title : Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert - Gil_1986_J.Pharmacol.Exp.Ther_237_577
Author(s) : Gil DW , Wolfe BB
Ref : Journal of Pharmacology & Experimental Therapeutics , 237 :577 , 1986
Abstract : Gil_1986_J.Pharmacol.Exp.Ther_237_577
ESTHER : Gil_1986_J.Pharmacol.Exp.Ther_237_577
PubMedSearch : Gil_1986_J.Pharmacol.Exp.Ther_237_577
PubMedID: 3009794

Title : Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase - Gil_1985_J.Pharmacol.Exp.Ther_232_608
Author(s) : Gil DW , Wolfe BB
Ref : Journal of Pharmacology & Experimental Therapeutics , 232 :608 , 1985
Abstract : Gil_1985_J.Pharmacol.Exp.Ther_232_608
ESTHER : Gil_1985_J.Pharmacol.Exp.Ther_232_608
PubMedSearch : Gil_1985_J.Pharmacol.Exp.Ther_232_608
PubMedID: 2579230